Literature DB >> 8308220

A case of cyclosporine-sensitive, steroid-resistant, autoimmune chronic active hepatitis.

J L Person1, J G McHutchison, T L Fong, A G Redeker.   

Abstract

Few alternative treatments are available for those patients with autoimmune chronic active hepatitis who fail to respond to the conventional treatment of corticosteroids. Such patients have a poor prognosis and frequently require liver transplantation. We report a patient with autoimmune hepatitis who failed treatment with corticosteroids and azathioprine. He responded to treatment with cyclosporine but relapsed with its discontinuation; reinstitution of the cyclosporine again induced remission. Cyclosporine appears to be an effective alternative treatment in patients with steroid-resistant, autoimmune chronic active hepatitis; its use may preclude or delay liver transplantation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8308220     DOI: 10.1097/00004836-199312000-00012

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  10 in total

Review 1.  [Therapy of autoimmune hepatitis].

Authors:  E G Rambusch; M P Manns
Journal:  Med Klin (Munich)       Date:  1999-03-15

Review 2.  The Contribution of B Cells in Autoimmune Liver Diseases.

Authors:  Sarah A Taylor; David N Assis; Cara L Mack
Journal:  Semin Liver Dis       Date:  2019-06-21       Impact factor: 6.115

3.  Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis.

Authors:  R Malekzadeh; S Nasseri-Moghaddam; M J Kaviani; H Taheri; N Kamalian; M Sotoudeh
Journal:  Dig Dis Sci       Date:  2001-06       Impact factor: 3.199

Review 4.  Difficult treatment decisions in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  World J Gastroenterol       Date:  2010-02-28       Impact factor: 5.742

Review 5.  Autoimmune hepatitis: focusing on treatments other than steroids.

Authors:  Albert J Czaja
Journal:  Can J Gastroenterol       Date:  2012-09       Impact factor: 3.522

Review 6.  Acute and acute severe (fulminant) autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-10-23       Impact factor: 3.199

Review 7.  Auto immune hepatitis.

Authors:  Nicole Mf van Gerven; Ynto S de Boer; Chris Jj Mulder; Carin Mj van Nieuwkerk; Gerd Bouma
Journal:  World J Gastroenterol       Date:  2016-05-21       Impact factor: 5.742

Review 8.  Autoimmune Hepatitis: Clinical Review with Insights into the Purinergic Mechanism of Disease.

Authors:  Nikhil Kapila; Jennifer T Higa; Maria Serena Longhi; Simon C Robson
Journal:  J Clin Transl Hepatol       Date:  2013-12-15

Review 9.  The use of immunosuppression in autoimmune hepatitis: A current literature review.

Authors:  Angela Cropley; Martin Weltman
Journal:  Clin Mol Hepatol       Date:  2017-03-14

Review 10.  Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments.

Authors:  Benedetta Terziroli Beretta-Piccoli; Giorgina Mieli-Vergani; Diego Vergani
Journal:  World J Gastroenterol       Date:  2017-09-07       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.